Targeting the Latent Reservoir for HIV-1

Srona Sengupta, Robert F Siliciano

Research output: Contribution to journalReview article

Abstract

Antiretroviral therapy can effectively block HIV-1 replication and prevent or reverse immunodeficiency in HIV-1-infected individuals. However, viral replication resumes within weeks of treatment interruption. The major barrier to a cure is a small pool of resting memory CD4+ T cells that harbor latent HIV-1 proviruses. This latent reservoir is now the focus of an intense international research effort. We describe how the reservoir is established, challenges involved in eliminating it, and pharmacologic and immunologic strategies for targeting this reservoir. The development of a successful cure strategy will most likely require understanding the mechanisms that maintain HIV-1 proviruses in a latent state and pathways that drive the proliferation of infected cells, which slows reservoir decay. In addition, a cure will require the development of effective immunologic approaches to eliminating infected cells. There is renewed optimism about the prospect of a cure, and the interventions discussed here could pave the way. Developing a cure for HIV-1 requires understanding the mechanisms of HIV-1 persistence in the latent reservoir. In this review, we discuss historical and recent paradigms in the HIV-1 persistence field as well as novel immunologic and pharmacologic strategies for eliminating this reservoir.

Original languageEnglish (US)
Pages (from-to)872-895
Number of pages24
JournalImmunity
Volume48
Issue number5
DOIs
StatePublished - May 15 2018

Fingerprint

HIV-1
Proviruses
Cell Proliferation
T-Lymphocytes
Research

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Cite this

Targeting the Latent Reservoir for HIV-1. / Sengupta, Srona; Siliciano, Robert F.

In: Immunity, Vol. 48, No. 5, 15.05.2018, p. 872-895.

Research output: Contribution to journalReview article

Sengupta, Srona ; Siliciano, Robert F. / Targeting the Latent Reservoir for HIV-1. In: Immunity. 2018 ; Vol. 48, No. 5. pp. 872-895.
@article{3be9845b0ed94600a233909f88632a37,
title = "Targeting the Latent Reservoir for HIV-1",
abstract = "Antiretroviral therapy can effectively block HIV-1 replication and prevent or reverse immunodeficiency in HIV-1-infected individuals. However, viral replication resumes within weeks of treatment interruption. The major barrier to a cure is a small pool of resting memory CD4+ T cells that harbor latent HIV-1 proviruses. This latent reservoir is now the focus of an intense international research effort. We describe how the reservoir is established, challenges involved in eliminating it, and pharmacologic and immunologic strategies for targeting this reservoir. The development of a successful cure strategy will most likely require understanding the mechanisms that maintain HIV-1 proviruses in a latent state and pathways that drive the proliferation of infected cells, which slows reservoir decay. In addition, a cure will require the development of effective immunologic approaches to eliminating infected cells. There is renewed optimism about the prospect of a cure, and the interventions discussed here could pave the way. Developing a cure for HIV-1 requires understanding the mechanisms of HIV-1 persistence in the latent reservoir. In this review, we discuss historical and recent paradigms in the HIV-1 persistence field as well as novel immunologic and pharmacologic strategies for eliminating this reservoir.",
author = "Srona Sengupta and Siliciano, {Robert F}",
year = "2018",
month = "5",
day = "15",
doi = "10.1016/j.immuni.2018.04.030",
language = "English (US)",
volume = "48",
pages = "872--895",
journal = "Immunity",
issn = "1074-7613",
publisher = "Cell Press",
number = "5",

}

TY - JOUR

T1 - Targeting the Latent Reservoir for HIV-1

AU - Sengupta, Srona

AU - Siliciano, Robert F

PY - 2018/5/15

Y1 - 2018/5/15

N2 - Antiretroviral therapy can effectively block HIV-1 replication and prevent or reverse immunodeficiency in HIV-1-infected individuals. However, viral replication resumes within weeks of treatment interruption. The major barrier to a cure is a small pool of resting memory CD4+ T cells that harbor latent HIV-1 proviruses. This latent reservoir is now the focus of an intense international research effort. We describe how the reservoir is established, challenges involved in eliminating it, and pharmacologic and immunologic strategies for targeting this reservoir. The development of a successful cure strategy will most likely require understanding the mechanisms that maintain HIV-1 proviruses in a latent state and pathways that drive the proliferation of infected cells, which slows reservoir decay. In addition, a cure will require the development of effective immunologic approaches to eliminating infected cells. There is renewed optimism about the prospect of a cure, and the interventions discussed here could pave the way. Developing a cure for HIV-1 requires understanding the mechanisms of HIV-1 persistence in the latent reservoir. In this review, we discuss historical and recent paradigms in the HIV-1 persistence field as well as novel immunologic and pharmacologic strategies for eliminating this reservoir.

AB - Antiretroviral therapy can effectively block HIV-1 replication and prevent or reverse immunodeficiency in HIV-1-infected individuals. However, viral replication resumes within weeks of treatment interruption. The major barrier to a cure is a small pool of resting memory CD4+ T cells that harbor latent HIV-1 proviruses. This latent reservoir is now the focus of an intense international research effort. We describe how the reservoir is established, challenges involved in eliminating it, and pharmacologic and immunologic strategies for targeting this reservoir. The development of a successful cure strategy will most likely require understanding the mechanisms that maintain HIV-1 proviruses in a latent state and pathways that drive the proliferation of infected cells, which slows reservoir decay. In addition, a cure will require the development of effective immunologic approaches to eliminating infected cells. There is renewed optimism about the prospect of a cure, and the interventions discussed here could pave the way. Developing a cure for HIV-1 requires understanding the mechanisms of HIV-1 persistence in the latent reservoir. In this review, we discuss historical and recent paradigms in the HIV-1 persistence field as well as novel immunologic and pharmacologic strategies for eliminating this reservoir.

UR - http://www.scopus.com/inward/record.url?scp=85046654695&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046654695&partnerID=8YFLogxK

U2 - 10.1016/j.immuni.2018.04.030

DO - 10.1016/j.immuni.2018.04.030

M3 - Review article

C2 - 29768175

AN - SCOPUS:85046654695

VL - 48

SP - 872

EP - 895

JO - Immunity

JF - Immunity

SN - 1074-7613

IS - 5

ER -